Idaho § 39-9407 PROHIBITIONS

Idaho Statutes

§ 39-9407 — PROHIBITIONS

Idaho § 39-9407

Title 39HEALTH AND SAFETY

Ch. 94RIGHT TO TRY ACT

This text of Idaho § 39-9407 (PROHIBITIONS) is published on Counsel Stack Legal Research, covering Idaho primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Idaho Code § 39-9407 (2026).

Text

(1)A licensing board or disciplinary body of this state shall not revoke, fail to renew, suspend or take any action against a health care provider’s license based solely on the provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device as allowed under this act.

(2)An entity responsible for medicare certification shall not take action against a health care provider’s medicare certification based solely on the health care provider’s recommendation that a patient have access to an investigational drug, biological product or device as allowed under this act.

(3)An official, employee or agent of this state shall not block or attempt to block an eligible patient’s access to an investigational drug, biological

Free access — add to your briefcase to read the full text and ask questions with AI

(1) A licensing board or disciplinary body of this state shall not revoke, fail to renew, suspend or take any action against a health care provider’s license based solely on the provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device as allowed under this act.
(2) An entity responsible for medicare certification shall not take action against a health care provider’s medicare certification based solely on the health care provider’s recommendation that a patient have access to an investigational drug, biological product or device as allowed under this act.
(3) An official, employee or agent of this state shall not block or attempt to block an eligible patient’s access to an investigational drug, biological product or device as allowed under this act.